Top compounds associated with response to GPR161


Feature Type Standardized
Nominal ANOVA
mRNA BRD-K27986637 CTRPv2 pan-cancer AAC 0.11 0.2
mRNA XMD13-2 GDSC1000 pan-cancer AAC 0.048 0.2
mRNA Cytarabine FIMM pan-cancer AAC 0.23 0.2
mRNA navitoclax:MST-312 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.057 0.2
mRNA BRD-K80183349 CTRPv2 pan-cancer AAC 0.051 0.2
mRNA Teniposide CTRPv2 pan-cancer AAC 0.06 0.2
mRNA Dasatinib GDSC1000 pan-cancer AAC -0.083 0.2
mRNA selumetinib:MK-2206 (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.054 0.2
mRNA Imatinib CTRPv2 pan-cancer AAC -0.055 0.2
mRNA PF-543 CTRPv2 pan-cancer AAC -0.057 0.2
Download CSV